823 results on '"Ferré, Sergi"'
Search Results
2. Pharmacological targeting of G protein-coupled receptor heteromers.
3. Significant Functional Differences Between Dopamine D4 Receptor Polymorphic Variants Upon Heteromerization with α1A Adrenoreceptors
4. Unique effect of clozapine on adenosine A2A-dopamine D2 receptor heteromerization
5. Presynaptic adenosine receptor heteromers as key modulators of glutamatergic and dopaminergic neurotransmission in the striatum
6. Targeting corticostriatal transmission for the treatment of cannabinoid use disorder
7. The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and function
8. Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox
9. Humanized dopamine D4.7 receptor male mice display risk‐taking behavior and deficits of social recognition and working memory in light/dark‐dependent manner
10. Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone
11. What Is the Role of Adenosine Tone and Adenosine Receptors in Huntington’s Disease?
12. Role of placebo effects in pain and neuropsychiatric disorders
13. Restless legs syndrome, neuroleptic-induced akathisia, and opioid-withdrawal restlessness: shared neuronal mechanisms?
14. Restless legs syndrome, neuroleptic-induced akathisia, and opioid-withdrawal restlessness: shared neuronal mechanisms?
15. Oligomerization of G protein-coupled receptors: Still doubted?
16. Allosterism Within GPCR Oligomers: Back to Symmetry
17. Fronto-striatal effective connectivity of working memory in adults with cannabis use disorder
18. Biased G Protein-Independent Signaling of Dopamine D1-D3 Receptor Heteromers in the Nucleus Accumbens
19. Revisiting the Functional Role of Dopamine D4 Receptor Gene Polymorphisms: Heteromerization-Dependent Gain of Function of the D4.7 Receptor Variant
20. Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas
21. Adenosine A1-Dopamine D1 Receptor Heteromers Control the Excitability of the Spinal Motoneuron
22. Synergistic Interaction between Adenosine A2A and Glutamate mGlu5 Receptors: Implications for Striatal Neuronal Function
23. In search of alternatives to dopaminergic ligands for the treatment of restless legs syndrome: iron, glutamate, and adenosine
24. Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation
25. Control of glutamate release by complexes of adenosine and cannabinoid receptors
26. Humanized dopamine D4.7 receptor male mice display risk‐taking behavior and deficits of social recognition and working memory in light/dark‐dependent manner.
27. Adenosine mechanisms and hypersensitive corticostriatal terminals in restless legs syndrome. Rationale for the use of inhibitors of adenosine transport
28. Dopamine D 1 and Adenosine A 1 Receptors Form Functionally Interacting Heteromeric Complexes
29. Allosteric Mechanisms in the Adenosine A2A-Dopamine D2 Receptor Heteromer
30. α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands
31. Choice Impulsivity
32. Significant Functional Differences Between Dopamine D4 Receptor Polymorphic Variants Upon Heteromerization with α1A Adrenoreceptors.
33. Clues from a missense mutation of the adenosine A1 receptor gene associated with early-onset Parkinson's disease
34. Hormones and Neuropeptide Receptor Heteromers in the Ventral Tegmental Area. Targets for the Treatment of Loss of Control of Food Intake and Substance Use Disorders
35. Allosteric interactions between agonists and antagonists within the adenosine A 2A receptordopamine D₂ receptor heterotetramer
36. Role of Striatal A2A Receptor Subpopulations in Neurological Disorders
37. Pharmacological targeting of G protein-coupled receptor heteromers
38. Brain-iron deficiency models of restless legs syndrome
39. Functional and pharmacological role of the dopamine D4 receptor and its polymorphic variants
40. Intracellular Calcium Levels Determine Differential Modulation of Allosteric Interactions within G Protein-Coupled Receptor Heteromers
41. Personality traits and vulnerability or resilience to substance use disorders
42. Consensus guidelines on the construct validity of rodent models of restless legs syndrome
43. List of Contributors
44. Adenosine Control of Striatal Function—Implications for the Treatment of Apathy in Basal Ganglia Disorders
45. Targeting hypersensitive corticostriatal terminals in restless legs syndrome
46. Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders
47. Preferential Gs protein coupling of the galanin Gal1 receptor in the µ-opioid-Gal1 receptor heterotetramer
48. Overcoming the Challenges of Detecting GPCR Oligomerization in the Brain
49. On the Nested Hierarchical Organization of CNS: Basic Characteristics of Neuronal Molecular Networks
50. Heteromerization of Adenosine and Dopamine Receptor Subtypes: Relevance for Neuronal Integration in Normal and Pathological States
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.